Patient-Focused Drug Development for a Single Intravenous Dose of HMI-203 Gene Therapy in Adult Mucopolysaccharidosis (MPS) II, or Hunter Syndrome, Patients

Haroldson J, Witalisz CJ, Martin R,. et al. ASHG 2021.